Your browser doesn't support javascript.
loading
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.
Beaton, Laura; Tregidgo, Henry F J; Znati, Sami A; Forsyth, Sharon; Clarkson, Matthew J; Bandula, Steven; Chouhan, Manil; Lowe, Helen L; Zaw Thin, May; Hague, Julian; Sharma, Dinesh; Pollok, Joerg-Matthias; Davidson, Brian R; Raja, Jowad; Munneke, Graham; Stuckey, Daniel J; Bascal, Zainab A; Wilde, Paul E; Cooper, Sarah; Ryan, Samantha; Czuczman, Peter; Boucher, Eveline; Hartley, John A; Lewis, Andrew L; Jansen, Marnix; Meyer, Tim; Sharma, Ricky A.
  • Beaton L; University College London Cancer Institute, University College London, London, United Kingdom.
  • Tregidgo HFJ; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
  • Znati SA; University College London Cancer Institute, University College London, London, United Kingdom.
  • Forsyth S; Cancer Research UK University College London Cancer Trials Centre, London, United Kingdom.
  • Clarkson MJ; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
  • Bandula S; University College London Centre for Medical Imaging, University College London, London, United Kingdom.
  • Chouhan M; University College London Centre for Medical Imaging, University College London, London, United Kingdom.
  • Lowe HL; University College London Experimental Cancer Medicine Centre Good Clinical Laboratory Practice Facility, University College London, London, United Kingdom.
  • Zaw Thin M; Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
  • Hague J; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Sharma D; Division of Transplantation and Immunology, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Pollok JM; Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Davidson BR; Hepatopancreatobiliary Surgery and Liver Transplantation, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Raja J; Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Munneke G; Hepatopancreatobiliary Surgery and Liver Transplantation, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Stuckey DJ; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Bascal ZA; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Wilde PE; Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
  • Cooper S; Biocompatibles UK Ltd, London, United Kingdom.
  • Ryan S; Biocompatibles UK Ltd, London, United Kingdom.
  • Czuczman P; Biocompatibles UK Ltd, London, United Kingdom.
  • Boucher E; Biocompatibles UK Ltd, London, United Kingdom.
  • Hartley JA; Biocompatibles UK Ltd, London, United Kingdom.
  • Lewis AL; Biocompatibles UK Ltd, London, United Kingdom.
  • Jansen M; University College London Cancer Institute, University College London, London, United Kingdom.
  • Meyer T; Biocompatibles UK Ltd, London, United Kingdom.
  • Sharma RA; University College London Cancer Institute, University College London, London, United Kingdom.
JMIR Res Protoc ; 8(10): e13696, 2019 Oct 02.
Article en En | MEDLINE | ID: mdl-31579027

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2019 Tipo del documento: Article